Fremanezumab for Preventive Treatment of Migraine

Fremanezumab is a humanized monoclonal antibody targeting calcitonin gene–related peptide (CGRP). It is administered monthly via SQ injection.

In this NEJM study, fremanezumab was effective as a preventive treatment for chronic migraine: http://www.nejm.org/doi/full/10.1056/NEJMoa1709038

Comments

Popular posts from this blog

10 Reasons Why People Like All Niche.

Glycemic index (GI) and glycemic load (GL) for 1,800 foods